The decreased levels of IL-17 shown in this study, a cytokine that correlates with BCG-mediated immunity against TB and is a predictor of recovery from tuberculosis, are worrisome for BCG’s future efficacy (27, 28). Here, IL17A is linked to tuberculosis.